Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Galmed Pharmaceuticals Ltd. logo — A clinical-stage drug development biopharmaceutical company...

Galmed Pharmaceuticals Ltd.

A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflammatory diseases

Founded 2000 Israel Israel 11 employees Post-IPO Equity Total: $103.60M Health Care, Pharmaceutical

General Information

Company Name Galmed Pharmaceuticals Ltd.
Founded Year 2000
Location Israel Israel
Founders / Decision Makers
Team member
Employees 11
Industries Health Care, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Galmed Pharmaceuticals Ltd.. To contact Galmed Pharmaceuticals Ltd., visit galmedpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, please visit our website at: www.galmedpharma.com

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $7.00M -
14 Jul 2023
Post IPO Equity $10.00M -
16 Feb 2021
Post IPO Equity $75.00M -
21 Jun 2018
Post IPO Equity $11.60M 2
Meitav Investment House, Sphera Funds Management
03 Jan 2018

Galmed Pharmaceuticals Ltd. Alternatives & Competitors

Galmed Pharmaceuticals Ltd. vs
Syntara
Syntara Australia

Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fibrosis and...

Post-IPO Equity
58 employees
Biotechnology, Health Care
Galmed Pharmaceuticals Ltd. vs
GEn1E Lifesciences Inc.
GEn1E Lifesciences Inc. United States

Clinical-stage, Phase 2 company accelerating novel Precision Therapies for I&I and Rare Diseases usi...

Series A
18 employees
AI, Biotechnology
Galmed Pharmaceuticals Ltd. vs
Melius Pharma
Melius Pharma Sweden

Clinical stage biopharma company developing treatments for diseases with high unmet needs at a reduc...

Series A
3 employees
Health Care, Pharmaceutical

FAQ About Galmed Pharmaceuticals Ltd.

A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflammatory diseases
Galmed Pharmaceuticals Ltd. was founded in 2000.
Galmed Pharmaceuticals Ltd. is headquartered in Israel.
Galmed Pharmaceuticals Ltd. operates in Health Care and Pharmaceutical.
Galmed Pharmaceuticals Ltd. has approximately 11 employees.
Galmed Pharmaceuticals Ltd. has completed 4 funding rounds, raising a total of $103.60M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Galmed Pharmaceuticals Ltd. include Syntara, GEn1E Lifesciences Inc., Melius Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Galmed Pharmaceuticals Ltd. and Syntara are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Galmed Pharmaceuticals Ltd., https://bouncewatch.com/company/galmed-pharmaceuticals-ltd, updated 28 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes